Literature DB >> 21725923

Does chronic kidney disease modify the association between body mass index and cardiovascular disease risk factors.

Nisha Bansal1, Eric Vittinghoff, Laura Plantinga, Chi-Yuan Hsu.   

Abstract

BACKGROUND: Excess weight is paradoxically associated with better cardiovascular disease (CVD) outcomes and mortality in end-stage renal disease (ESRD) patients treated with hemodialysis. This association has been observed in chronic kidney disease (CKD) as well. One potential explanation for this inverse relationship is that the usual positive correlation between severity of CVD risk factors and higher body mass index (BMI) is reversed in CKD. To test this hypothesis, we determined the relationship between BMI and CVD risk factors in patients with and without CKD.
METHODS: This was a cross-sectional study of the nationally representative US National Health and Nutrition Examination Survey (NHANES) 1999-2006. CKD was defined as glomerular filtration rate <60 ml/min per 1.73 m2. Covariates were age, race/ethnicity, sex and use of relevant prescription medications. Outcome variables were total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, systolic blood pressure (SBP), diastolic blood pressure (DBP), C-reactive protein (CRP) and fasting glucose (FG).
RESULTS: There were 1,895 and 32,431 patients with and without CKD, respectively. Those with CKD were older and had higher BMI. The shapes of the association between BMI and total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, SBP, CRP and FG were similar in those with or without CKD. In a sensitivity analysis excluding patients taking relevant prescription medications, our results did not differ substantially.
CONCLUSIONS: CKD did not alter the shapes of the association between higher BMI and CVD risk factors. Inverse associations between BMI and CVD risk factors are unlikely to explain why CKD patients with higher BMI may have better outcomes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21725923      PMCID: PMC3740720          DOI: 10.5301/JN.2011.8454

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  40 in total

1.  Prevalence of paradoxically normal serum cholestrol in morbidly obese women.

Authors:  H Vierhapper; A Nardi; P Grösser
Journal:  Metabolism       Date:  2000-05       Impact factor: 8.694

2.  Causes and consequences of the reverse epidemiology of body mass index in dialysis patients.

Authors:  Kamyar Kalantar-Zadeh
Journal:  J Ren Nutr       Date:  2005-01       Impact factor: 3.655

3.  Markers of arterial stiffness are risk factors for progression to end-stage renal disease among patients with chronic kidney disease stages 4 and 5.

Authors:  Maarten W Taal; Mhairi K Sigrist; Apostolos Fakis; Richard J Fluck; Christopher W McIntyre
Journal:  Nephron Clin Pract       Date:  2007-11-01

4.  Reduced glomerular filtration rate in pre-dialysis non-diabetic chronic kidney disease patients is associated with impaired baroreceptor sensitivity and reduced vascular compliance.

Authors:  Peter Lacy; Susan J Carr; David O'Brien; Barbara Fentum; Bryan Williams; Sanjoy K Paul; Thompson G Robinson
Journal:  Clin Sci (Lond)       Date:  2006-01       Impact factor: 6.124

5.  Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Authors:  S F Leavey; K McCullough; E Hecking; D Goodkin; F K Port; E W Young
Journal:  Nephrol Dial Transplant       Date:  2001-12       Impact factor: 5.992

6.  Body mass index and the prevalence of hypertension and dyslipidemia.

Authors:  C D Brown; M Higgins; K A Donato; F C Rohde; R Garrison; E Obarzanek; N D Ernst; M Horan
Journal:  Obes Res       Date:  2000-12

Review 7.  Cholesterol-independent effects of statins in inflammation, immunomodulation and atherosclerosis.

Authors:  Claire Arnaud; Niels R Veillard; François Mach
Journal:  Curr Drug Targets Cardiovasc Haematol Disord       Date:  2005-04

Review 8.  Survival advantages of obesity in dialysis patients.

Authors:  Kamyar Kalantar-Zadeh; Kevin C Abbott; Abdulla K Salahudeen; Ryan D Kilpatrick; Tamara B Horwich
Journal:  Am J Clin Nutr       Date:  2005-03       Impact factor: 7.045

9.  Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group.

Authors:  N B Shulman; C E Ford; W D Hall; M D Blaufox; D Simon; H G Langford; K A Schneider
Journal:  Hypertension       Date:  1989-05       Impact factor: 10.190

10.  An association between decreased estimated glomerular filtration rate and arterial stiffness.

Authors:  Ryuichi Kawamoto; Katsuhiko Kohara; Yasuharu Tabara; Tetsuro Miki; Nobuyuki Ohtsuka; Tomo Kusunoki; Nobukazu Yorimitsu
Journal:  Intern Med       Date:  2008-04-01       Impact factor: 1.271

View more
  4 in total

1.  Physical Activity and Cardiovascular Risk among Kidney Transplant Patients.

Authors:  Augustine W Kang; Carol Ewing Garber; Charles B Eaton; Patricia M Risica; Andrew G Bostom
Journal:  Med Sci Sports Exerc       Date:  2019-06       Impact factor: 5.411

2.  Pre-ESRD changes in body weight and survival in nursing home residents starting dialysis.

Authors:  Shobha Stack; Glenn M Chertow; Kirsten L Johansen; Yan Si; Manjula Kurella Tamura
Journal:  Clin J Am Soc Nephrol       Date:  2013-09-05       Impact factor: 8.237

3.  Voluntary wheel running augments aortic l-arginine transport and endothelial function in rats with chronic kidney disease.

Authors:  Christopher R Martens; James M Kuczmarski; Jahyun Kim; John J Guers; M Brennan Harris; Shannon Lennon-Edwards; David G Edwards
Journal:  Am J Physiol Renal Physiol       Date:  2014-06-25

4.  Serum C-reactive protein levels in pre-dialysis chronic kidney disease patientsin southern Nigeria.

Authors:  Oluseyi A Adejumo; Enajite I Okaka; Chimezie G Okwuonu; Ikponmwosa O Iyawe; Oluwole O Odujoko
Journal:  Ghana Med J       Date:  2016-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.